Unity Biotechnology Inc lost $1.54 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q2 FY2024 through Q1 FY2025, the same line adds up to a loss of $1.62 per diluted share. The table below carries 9 fiscal years, from 2016 to 2024, and the quarters Unity Biotechnology Inc has filed alongside them.
FY2024 annual
EPS (Diluted)-$1.54
YoYn/m
Source SEC FilingsLatest period Q1 FY2025, ended Mar 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
UNBX EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Unity Biotechnology Inc lost $1.54 per diluted share in fiscal year 2024.
Unity Biotechnology Inc (UNBX) reported a loss of $2.70 per diluted share in fiscal year 2023 and a loss of $1.54 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Unity Biotechnology Inc (UNBX) reported a loss of $1.62 per diluted share over the trailing 12 months, Q2 FY2024 through Q1 FY2025, summed from the four most recent quarterly filings.
Across the 9 fiscal years this page covers, Unity Biotechnology Inc (UNBX) diluted earnings per share went from -$11.42 in fiscal year 2016 to -$1.54 in fiscal year 2024.
Unity Biotechnology Inc (UNBX) reported -$0.43 in diluted earnings per share in Q1 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Unity Biotechnology Inc (UNBX) reported on that line in every period on record.
